Aegon Ltd. research snapshot
AEG AI stock analysis currently reads Aegon Ltd. as a multi-line life, retirement, and asset-management group that is becoming a more US-centered franchise under Transamerica, with the sale of Aegon UK to Standard Life agreed, a EUR 200 million buyback running, and the legal seat and head office moving toward the United States. At the August 3, 2026 data cutoff, AEG closed at $9.44 on July 31, 2026 with an independently verified market capitalization of about $14.01 billion. This page uses scenarios, technical levels, and source-backed facts. It is informational research, not investment advice.
Current price
$9.44
Market cap
$14.01 billion
AI score
69 / 100
Rating
US-focused life and retirement group with active capital returns
Trend status
Constructive uptrend above 50-day and 200-day averages, near the 52-week high
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Aegon is primarily a life, retirement, and asset-management group whose customers pay for protection, retirement income, and distribution through brands such as Transamerica and World Financial Group. The UK unit is being sold so the group can sharpen its US focus. | Medium-high |
| Moat | The moat is moderate: WFG agent scale, Transamerica brand recognition, and installed books of business help, but product pricing power is limited and competitors can copy distribution models over time. | Medium |
| Management | CEO Lard Friese was proposed for a term extension to 2030, Will Fuller will become President and COO effective January 1, 2027, New York City was selected for the future head office, and the Delaware redomicile is advancing with a vote planned for Q4 2026. | Medium-high |
| Financial trend | FY2025 IFRS operating result rose 15% to EUR 1.7 billion, operating capital generation reached EUR 1.3 billion and beat the EUR 1.2 billion target, free cash flow was EUR 829 million, and the company returned about EUR 1.1 billion via dividends and buybacks. | High |
| Valuation | At $9.44, AEG traded near 12.9x to 13.7x trailing earnings, about 1.26x book equity, and a dividend yield that depends on whether markets price the full-year EUR 0.40 DPS or the partial cash distributions shown in the ADR yield field. | Medium |
| Technical trend | As of July 31, 2026, StockAnalysis showed the ADR above its 50-day average of $8.69 and 200-day average of $7.91, with RSI at 69.48 and price pressing the $9.49 52-week high. | Medium-high |
| Risk level | Key risks include interest-rate and equity-market shocks, mortality and policyholder-behavior experience, legacy secondary-guarantee blocks, currency translation, UK sale closing conditions, and redomicile execution. | Medium-high |
| AI confidence | High for descriptive research and market-cap math. Lower for precise multi-year price targets because life-insurer earnings and capital generation can reprice quickly after assumption updates or market moves. | High data confidence |
| Investment certainty | Medium certainty. Capital returns and a signed UK exit support a constructive bias, but a buy decision still depends on price near the 52-week high, legacy-risk tolerance, and trust in the Transamerica-centered strategy. | Medium |
AEG AI stock forecast
The AEG AI stock forecast uses scenario math around the $9.44 ADR quote and about $0.69 trailing EPS. An audited three-year framework with 8%/4%/0% EPS growth and 14x/11x/8x exit multiples produced a bullish area near $12, a base area near $8.50, and a bearish area near $5.50 before dividends. Because the ADR now trades near its 52-week high, the base case sits below the current quote, which means the market already prices in much of the base-case path.
$11 to $13
More likely if the UK sale to Standard Life closes around the end of 2026, buybacks keep shrinking the share count, US individual life and retirement growth stays strong, the redomicile proceeds, and investors re-rate AEG toward the mid-teens PE zone.
$8 to $9
More likely if EPS compounds near mid-single digits, the pro-forma operating result run-rate grows about 5% a year from EUR 1.3 to 1.5 billion, free cash flow stays near the EUR 0.8 billion run-rate, dividends rise modestly, and the market keeps AEG around a low-double-digit earnings multiple.
$5 to $6
More likely if adverse policyholder behavior, market shocks, legacy-block losses, UK deal or redomicile friction, or failed capital-return plans compress earnings and force a high-single-digit PE.
AEG AI technical analysis
AEG AI technical analysis is constructive as of the August 3, 2026 cutoff, based on the July 31, 2026 close. StockAnalysis reported the ADR at $9.44, above a 50-day simple moving average of $8.69 and a 200-day simple moving average of $7.91, with a 14-day RSI of 69.48, a five-year beta of 0.63, and about 5.25 million average 20-day volume. The stock is pressing its 52-week high of $9.49.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $9.44 | NYSE ADR close on July 31, 2026, used for market-cap and valuation math at the August 3, 2026 cutoff. |
| Near support | $9.00 to $9.18 | The late-July consolidation zone where the ADR repeatedly found buyers. A hold here keeps the near-term trend intact. |
| Secondary support | $8.69 to $8.75 | The 50-day moving average of $8.69 and the early-July low area cluster here. This is the first meaningful trend warning zone. |
| Deeper support | $8.44 to $8.55 | Late-June swing area and prior volume support. A break below this band would signal a larger pullback from the 52-week high run. |
| Near resistance | $9.49 | The 52-week high. Follow-through above it with volume would extend the uptrend toward the $10 area. |
| Next resistance | $10.00 | A psychological round level and the next logical target after a confirmed break above $9.49. |
| 50-day moving average | $8.69 | Price is above the 50-day average, supporting the intermediate trend unless the ADR closes below it. |
| 200-day moving average | $7.91 | Price is well above the 200-day average, keeping the longer-term trend constructive unless it breaks. |
| Momentum | 14-day RSI of 69.48 | RSI is elevated and approaching overbought on the daily frame, which can precede consolidation or a pullback. |
| Volume | About 5.25 million average daily shares | StockAnalysis listed about 5.25 million average 20-day volume, enough for liquid large-cap ADR trading. |
| Volatility | Beta about 0.63 | StockAnalysis listed a five-year beta of 0.63, but insurer-specific assumption updates and market moves can still create sharp ADR swings. |
| Invalidation | Close below $8.69, then $8.44 | A close below the 50-day average would weaken the short-term bullish setup. A break of the $8.44 swing area would be a deeper trend warning. |
AEG AI trading strategy
The AEG AI trading strategy is a rules-based research framework for a life and retirement group that is selling its UK unit, running buybacks, and relocating to the United States. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls.
Watch for AEG to hold above the $9.00 to $9.18 zone and clear the $9.49 52-week high with volume confirmation after the UK sale close, buyback updates, or redomicile milestones.
A close below $8.69 or a failed breakout after a capital or legacy-risk headline should invalidate the short-term setup.
If AEG pulls back toward the $8.44 to $8.69 zone without a new adverse assumption update, UK-deal setback, or capital-ratio shock, compare the reaction with free cash flow, OCG, and buyback activity.
Do not average down without a defined loss limit because life-insurer books can reprice quickly after experience or market shocks.
Track US individual life sales, WFG agent count, Retirement Plans assets, operating capital generation, free cash flow, Cash Capital at Holding, valuation equity per share, UK sale closing progress, buyback completion, and redomicile vote milestones.
Reduce confidence if capital returns rely mainly on leverage or one-time releases instead of recurring OCG and free cash flow.
Investment research summary
Customers pay Aegon for life protection, retirement savings, annuities, and investment products. Value creation comes from underwriting and fee income, investment returns on insurance float, distribution scale through Transamerica and WFG, and returning excess capital to shareholders. The UK business is being sold to Standard Life to make the group a sharper US life and retirement franchise.
The moat is strongest in distribution reach, brand recognition, and the installed book of policies. It narrows when competitors underprice protection products, when independent agents leave, or when legacy blocks force capital into runoff instead of growth.
The thesis fails if interest-rate or equity shocks hit capital generation, policyholder behavior worsens on guarantee-heavy products, the UK sale or Delaware redomicile stalls, or management over-distributes capital and weakens solvency buffers.
Friese met the 2023 CMD financial targets in 2025, is proposed for a term extension to 2030, and is driving a US-centered strategy. Fuller becomes President and COO in January 2027, New York City will host the future head office, and the company plans to rename the holding company Transamerica Inc. after redomiciliation.
Aging populations, retirement under-saving, and demand for protection support long-term life and retirement products, especially in the US. The industry remains competitive and capital intensive, so growth only creates value when new business and experience variance stay disciplined.
AEG trades near a low-double-digit earnings multiple and modestly above book equity, at the top of its 52-week range. Margin of safety depends on recurring free cash flow, the quality of US Strategic Assets growth, the runoff cost of legacy risk, and whether the market keeps trusting the multi-year US pivot.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AEG price | $9.44 close on July 31, 2026 | StockAnalysis quote snapshot | August 3, 2026 |
| Market capitalization | $14.01 billion, verified as $9.44 x about 1.51 billion ADR-equivalent shares | financial_rigor.py market cap verification and StockAnalysis | August 3, 2026 |
| Shares outstanding | About 1.51 billion, down about 4.75% year over year on buybacks | StockAnalysis statistics | August 3, 2026 |
| FY2025 IFRS operating result | EUR 1.7 billion, up 15% versus 2024 | Aegon 2H 2025 results press release | August 3, 2026 |
| FY2025 net result | EUR 980 million, up 45% versus 2024 | Aegon 2H 2025 results press release | August 3, 2026 |
| FY2025 operating capital generation | EUR 1.3 billion before holding funding, exceeding the EUR 1.2 billion target | Aegon 2H 2025 results press release | August 3, 2026 |
| FY2025 free cash flow | EUR 829 million, consistent with the about EUR 800 million target | Aegon 2H 2025 results press release | August 3, 2026 |
| FY2025 dividend | EUR 0.40 per common share full-year target met | Aegon 2H 2025 results press release | August 3, 2026 |
| Valuation equity per share | EUR 9.06 at year-end 2025, up 7% in the reporting period | Aegon 2H 2025 results press release | August 3, 2026 |
| Aegon UK sale | GBP 2.0 billion total consideration (15.3% Standard Life stake plus GBP 0.75 billion cash), about 14.2x 2025 operating result after tax; close expected around end 2026 | Aegon UK sale press release, April 15, 2026 | August 3, 2026 |
| Share buybacks | EUR 227 million buyback completed June 30, 2026; EUR 200 million buyback running since July 1, 2026 with completion expected by December 23, 2026 | Aegon share buyback press release, July 1, 2026 | August 3, 2026 |
| US relocation plan | New York City selected for future head office; Delaware legal seat planned with shareholder vote in Q4 2026 and redomicile target around January 1, 2028 | Aegon leadership and head office press release, June 17, 2026 | August 3, 2026 |
| Trailing PE and book multiple | About 12.9x to 13.7x trailing PE, about 1.26x price to book | StockAnalysis statistics and financial_rigor.py valuation check | August 3, 2026 |
| TTM EPS (ADR) | About $0.69 | StockAnalysis overview | August 3, 2026 |
| Technical snapshot | Price $9.44 above SMA50 $8.69 and SMA200 $7.91; RSI 69.48; beta 0.63; 52-week range $6.75 to $9.49 | StockAnalysis statistics | August 3, 2026 |
This AEG AI stock analysis is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available public data as of the cutoff date, may be wrong, and should be checked against current filings, market data, capital-generation reports, and personal risk constraints.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
